Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1


So excited to present initial results of Patriot-II study at #GU23 @ASCO thankful to patients, all investigators/st… https://t.co/pgw42ChPnh

  • 123456 Profile photo of Madelyn

    We presented the initial findings from the PATRIOT-II study looking at real world data on first line therapy in advanced urothelial Ca with induction chemo followed by switch maintenance avelumab in patients without progression